SOD1 and Huntington disease: β-BA also reduced AChE [one-way ANOVA:F (6, 30) = 1.175, p < 0.01] (Figure 9A), MDA [one-way ANOVA: F (6, 30) = 0.5999, p < 0.01] (Figure 9B), GSH [one-way ANOVA: F (6, 30) = 1.003, p < 0.01] (Figure 9C), SOD [One-way ANOVA:F (6, 30) = 1.195, p < 0.01] (Figure 9D), CAT [one-way ANOVA:F (6, 30) = 1.274, p < 0.01] (Figure 9E) level in a dose-dependent manner in 3-NP-induced HD in rats.